• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall RayStation 11A, RayStation 11A SP1, RayStation 11A SP2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall RayStation 11A, RayStation 11A SP1, RayStation 11A SP2see related information
Date Initiated by FirmOctober 07, 2026
Date PostedNovember 18, 2026
Recall Status1 Open3, Classified
Recall NumberZ-0487-2027
Recall Event ID 100093
510(K)NumberK211867 
Product Classification System, planning, radiation therapy treatment - Product Code MUJ
ProductRayStation Systems: RayStation 11A, RayStation 11A SP1, RayStation 11A SP2. Model/Build Numbers: 11.0.0.951, 11.0.1.29, 11.0.3.116 Radiation Therapy Treatment Planning System
Code Information Model/Build Numbers: 11.0.0.951, 11.0.1.29, 11.0.3.116. UDI: 0735000201038920210518, 0735000201043320210610, 0735000201044020210916. GTIN: 07350002010389, 07350002010433, 07350002010440. Serial Numbers: 11.0.0.951, 11.0.1.29, 11.0.3.116. Software Revision: RayStation 11A, RayStation 11A SP1, RayStation 11A SP2. Expiration Date: 2026-05-25, 2026-06-17, 2026-10-14.
FEI Number 3007774465
Recalling Firm/
Manufacturer
RAYSEARCH LABORATORIES AB
Eugeniavagen 18c
Stockholm Sweden
For Additional Information ContactPierpaolo Sesana
0046-85-1053000
Manufacturer Reason
for Recall
Potential for dose deformation after using a deformable registration that expands outwards near the boundary of the original dose grid, possibly causing the clinically relevant dose to be lost.
FDA Determined
Cause 2
Under Investigation by firm
ActionRaySearch notified consignees on about 10/07/2026 via "Field Safety Notice" Letter. Consignees were instructed to exercise caution when deforming dose using a deformable registration that is expanding outwards in the region close to the boundary of the original dose grid, review deformed dose carefully before using it for dose accumulation or treatment evaluation, ensure that the dose grid extends with a sufficient margin around regions where the deformable registration may expand outward, educate planning staff and all users about the workaround, inspect all installed units on hand with affected software version, and complete and return the response form. This issue will be resolved in the next version of RayStation, scheduled for market release in December 2026 (subject to market clearance in some markets). If customers wish to continue using versions of RayStation affected by this notice, all users must maintain awareness of this notice. Alternatively, customers can choose to upgrade to the new version once it becomes available for clinical use.
Quantity in Commerce7 units
DistributionWorldwide - US Nationwide distribution.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
510(K) Database510(K)s with Product Code = MUJ
-
-